TECTONIC THERAPEUTIC, INC. Shareholders' Equity
TECTONIC THERAPEUTIC, INC. (TECX) had Shareholders' Equity of $223.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $223.85M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $230.42M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $251.33M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $267.53M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $223.85M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $230.42M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $251.33M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $267.53M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $283.77M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $301.04M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $140.78M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $150.36M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $166.37M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | -$99.57M 10-Q · filed 2025-11-06 | $88.84M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$84.64M 10-K · filed 2026-02-26 | $94.74M 10-K · filed 2024-03-14 |
| 2023-09-30 | -$79.78M 10-Q · filed 2024-11-12 | $102.86M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$70.00M 10-Q · filed 2024-11-12 | $122.04M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$59.82M 10-Q · filed 2024-11-12 | $53.00M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$45.65M 10-K · filed 2025-03-20 | $75.37M 10-K · filed 2023-03-23 |
| 2022-09-30 | $98.09M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $118.34M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $143.16M 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $169.48M 10-K · filed 2024-03-14 | |
| 2021-09-30 | $193.57M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $220.99M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $232.93M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $254.34M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $207.87M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $239.79M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $256.52M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $186.01M 10-K · filed 2022-03-17 | |
| 2019-09-30 | $206.76M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $92.63M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $106.79M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $122.18M 10-K · filed 2021-03-18 | |
| 2018-09-30 | $137.11M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $148.32M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | -$33.51M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | -$23.14M 10-K · filed 2020-03-16 | |
| 2016-12-31 | -$4.58M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |